Trans-sialidase delivered as a naked DNA vaccine elicits an immunological response similar to a Trypanosoma cruzi infection
- PMID: 10347760
- DOI: 10.1590/s0100-879x1999000200013
Trans-sialidase delivered as a naked DNA vaccine elicits an immunological response similar to a Trypanosoma cruzi infection
Abstract
Trypanosoma cruzi. the protozoan parasite that causes Chagas' disease, does not synthesize sialic acid, but expresses a trans-sialidase (TS) that catalyzes the transfer of sialic acid from host glycoconjugates to the parasite surface. Here, we review studies that characterize the immune response to the catalytic domain of the enzyme in humans during Chagas' disease or in mice following immunization with the TS gene. In both cases, there are antibodies that strongly inhibit the enzymatic activity and generation of interferon-gamma-producing T cells.
Similar articles
-
Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice.Vaccine. 1998 May;16(8):768-74. doi: 10.1016/s0264-410x(97)00277-6. Vaccine. 1998. PMID: 9627933
-
Comparison of antibody and protective immune responses against Trypanosoma cruzi infection elicited by immunization with a parasite antigen delivered as naked DNA or recombinant protein.Parasite Immunol. 1999 Feb;21(2):103-10. doi: 10.1046/j.1365-3024.1999.00201.x. Parasite Immunol. 1999. PMID: 10101720
-
Trypanosoma cruzi trans-sialidase: enhancement of virulence in a murine model of Chagas' disease.J Exp Med. 1995 May 1;181(5):1693-703. doi: 10.1084/jem.181.5.1693. J Exp Med. 1995. PMID: 7722448 Free PMC article.
-
The trans-sialidase, the major Trypanosoma cruzi virulence factor: Three decades of studies.Glycobiology. 2015 Nov;25(11):1142-9. doi: 10.1093/glycob/cwv057. Epub 2015 Jul 29. Glycobiology. 2015. PMID: 26224786 Review.
-
Parasite-host glycan interactions during Trypanosoma cruzi infection: trans-Sialidase rides the show.Biochim Biophys Acta Mol Basis Dis. 2020 May 1;1866(5):165692. doi: 10.1016/j.bbadis.2020.165692. Epub 2020 Jan 20. Biochim Biophys Acta Mol Basis Dis. 2020. PMID: 31972227 Free PMC article. Review.
Cited by
-
Theft and Reception of Host Cell's Sialic Acid: Dynamics of Trypanosoma Cruzi Trans-sialidases and Mucin-Like Molecules on Chagas' Disease Immunomodulation.Front Immunol. 2019 Feb 6;10:164. doi: 10.3389/fimmu.2019.00164. eCollection 2019. Front Immunol. 2019. PMID: 30787935 Free PMC article. Review.
-
Intranasal vaccinations with the trans-sialidase antigen plus CpG Adjuvant induce mucosal immunity protective against conjunctival Trypanosoma cruzi challenges.Infect Immun. 2010 Mar;78(3):1333-8. doi: 10.1128/IAI.00278-09. Epub 2010 Jan 4. Infect Immun. 2010. PMID: 20048046 Free PMC article.
-
Production of recombinant TSA-1 and evaluation of its potential for the immuno-therapeutic control of Trypanosoma cruzi infection in mice.Hum Vaccin Immunother. 2019;15(1):210-219. doi: 10.1080/21645515.2018.1520581. Epub 2018 Sep 21. Hum Vaccin Immunother. 2019. PMID: 30192702 Free PMC article.
-
DNA Vaccines against Protozoan Parasites: Advances and Challenges.J Biomed Biotechnol. 2007;2007(6):90520. doi: 10.1155/2007/90520. J Biomed Biotechnol. 2007. PMID: 17710244 Free PMC article.
-
Enzyme-linked immunoassay using recombinant trans-sialidase of Trypanosoma cruzi can be employed for monitoring of patients with Chagas' disease after drug treatment.Clin Diagn Lab Immunol. 2003 Sep;10(5):826-30. doi: 10.1128/cdli.10.5.826-830.2003. Clin Diagn Lab Immunol. 2003. PMID: 12965912 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical